Mikayla Quigley

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Rocio García‐Carbonero, Jeff Supko, Judith Manola et al. · Journal of Clinical Oncology · 2004 · 292 citations · Full text

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Rocio García‐Carbonero, Jeffrey G. Supko, Robert G. Maki et al. · Journal of Clinical Oncology · 2005 · 191 citations · Full text

Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas

Palma Dileo, Jeffrey A. Morgan, David Zahrieh et al. · Cancer · 2007 · 77 citations · Full text

Vitamin D Modulation of Mitochondrial Oxidative Metabolism and <scp>mTOR</scp> Enforces Stress Adaptations and Anticancer Responses

Mikayla Quigley, Sandra Rieger, Enrico Capobianco et al. · JBMR Plus · 2021 · 38 citations · Full text

Inhibition of the Heat Shock Protein 90 (Hsp90) chaperone with the novel agent IPI-504 to overcome resistance to tyrosine kinase inhibitors (TKIs) in metastatic GIST: Updated results of a phase I trial

George D. Demetri, Suzanne George, Jeffrey A. Morgan et al. · Journal of Clinical Oncology · 2007 · 25 citations

Immunology, Kinase Inhibitors, Pathology +23